|
Mapping
the vet and pet market
The $16 billion animal healthcare market may not be a traditional
diversification strategy for Indian pharmaceutical players.
But with a steady CAGR of five to six percent, some savvy
Indian players have ambitious plans. Manjusha Morgaonkar explores
Ranbaxy-NPPA
legal wrangle to continue
Ranbaxy Laboratories looks set to lock horns once again with
the government and the drug price regulator National Pharmaceutical
Pricing Authority (NPPA) for fixing price of Roscillin, one
of their most profitable brands.
The
rising story
Suja Nair analyses the performance of the companies who have
gained and lost in the rat race
NPIL
in pact with DxTech
Nicholas Piramal India Limited (NPIL, name proposed to be
changed to Piramal Healthcare Limited), has entered into a
long-term strategic alliance with DxTech LLC (DxTech).
Intas
to launch Filgrastim
Intas Biopharmaceuticals Limited (IBPL) has signed an agreement
with Canada based Apotex for co-development and supply of
its Filgrastim brand, Neukine, in North America (US and Canada).
Bilcare
GCS forms corporate advisory board
Bilcare Global Clinical Supplies (GCS) has formed its first
corporate advisory board. Mohan Bhandari, Chairman and Managing
Director, Bilcare, announced that John LaMattina, former President,
Pfizer, and Arthur Carty, Executive Director, Waterloo Institute
of Nanotechnology as the board's inaugural members.
Dr
Reddy's acquires BASF's contract manufacturing business
Dr Reddy's Laboratories (DRL) has signed a definitive agreement
to acquire BASF's pharmaceutical contract manufacturing business
and related facility in Shreveport, Louisiana, USA.
Suven
secures European product patent
The European Patent Office (EPO) has granted Suven the product
patent, EP 1581492, to its clinical candidate SUVN-502 that
is valid until June 2023.
Double
gain for Lupin
Lupin's subsidiary in Japan, Kyowa Pharmaceutical (Kyowa),
has received approvals for 10 products from the Ministry of
Health and Labour Welfare (MHLW), Japan, and expects to launch
these in July 2008 post National Health Insurance (NHI) listing.
Strides
in pact with Genepharm
Strides has signed a definitive agreement with Genepharm Australasia
Limited (GAA).
Aventis
Pharma launches SoloSTAR
Aventis Pharma (group Sanofi-Aventis) launched a new pre-filled
disposable insulin pen, SoloSTAR for use with the 24-hour
insulin LANTUS.
Advinus
achieves milestones in Merck deal
Advinus Therapeutics, the TATA promoted company engaged in
pharmaceutical R&D, has achieved two more milestones,
one each in the two programs under drug discovery and development
collaboration between Advinus and Merck.
Cadila
to expand through units in pharma SEZ Park
Cadila Pharmaceuticals Limited (CPL) is to set up nearly eight
units in its upcoming pharma Special Economic Zone (SEZ) Park
near Ahmedabad.
GSK
Pharma signs agreement with Astellas
GlaxoSmithKline (GSK) Pharma signed a collaboration agreement
with Japan based Astellas Pharma for exclusive rights for
the latter's injectible anti-fungal agent micafungin (brand
name Mycamine) in the Indian market.
New
drug development course
A certificate course in clinical research has been started
as a part of the initiatives taken by Apollo Hospitals Research
and Education Foundation (AHERF), New Delhi, in a joint venture
with government regulatory body and drug industry.
ICRI
introduces an innovative method of learning
Institute of Clinical Research India, (ICRI), introduced a
revolutionary teaching methodology - 'Blackboard (Virtual
Learning Environment).
First
state conference of CIPMMA held at Chennai
Consortium of Indian Pharmaceutical Manufacturers and Marketers
Association (CIPMMA) conducted its first state conference
in Chennai on May 1 2008.
Exchanging
ideas at AIDCOC Convention 2008
All India Drugs Control Officers Confederation (AIDCOC), representing
drug control officers in India, organised the 11th Annual
Convention, AIDCOC Convention 2008 at Indira Gandhi Institute
of Development Research, Mumbai on 26th and 27th April 2008.
Event
Brief
'We
want to build upon changes in the Indian market'
After US, Mumbai became the third city to host a Drug Information
Association (DIA) office. Linda McGoldrick, Executive Director,
DIA, speaks to Arshiya Khan on DIA's plans for India
|
